Bioceltix S.A. (WSE:BCX)
89.50
+1.60 (1.82%)
Jun 12, 2026, 5:00 PM CET
Bioceltix Employees
Bioceltix had 43 employees as of December 31, 2025. The number of employees increased by 7 or 19.44% compared to the previous year.
Employees
43
Change
7
Growth
19.44%
Revenue / Employee
n/a
Profits / Employee
-396.35K PLN
Market Cap
495.14M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 43 | 7 | 19.44% |
| Sep 30, 2025 | 41 | 14 | 51.85% |
| Jun 30, 2025 | 36 | 9 | 33.33% |
| Mar 31, 2025 | 35 | 8 | 29.63% |
| Dec 31, 2024 | 36 | 8 | 28.57% |
| Sep 30, 2024 | 27 | 1 | 3.85% |
| Mar 31, 2024 | 27 | 7 | 35.00% |
| Dec 31, 2023 | 28 | 8 | 40.00% |
| Sep 30, 2023 | 26 | 6 | 30.00% |
| Mar 31, 2023 | 20 | 6 | 39.96% |
| Dec 31, 2022 | 20 | 6 | 39.96% |
| Sep 30, 2022 | 20 | - | - |
| Mar 31, 2022 | 14 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| BIOTON | 364 |
| Ryvu Therapeutics | 228 |
| Synthaverse | 214 |
| Mabion | 204 |
| Captor Therapeutics Spolka Akcyjna | 82 |
| Molecure | 71 |
| Poltreg | 37 |
| Urteste | 36 |
Bioceltix News
- 15 days ago - Bioceltix Quarterly report: Q1 2026 - Filings
- 6 weeks ago - Bioceltix Annual report: Q4 2025 - Filings
- 2 months ago - Bioceltix Slides: Company presentation - Filings
- 4 months ago - Certain BlackRock Closed-End Funds Announce Estimated Sources of Distributions - Business Wire
- 7 months ago - Bioceltix Quarterly report: Q3 2025 - Filings
- 8 months ago - 5 High Yield CEFs With Steep Discounts Right Now - Forbes
- 9 months ago - Bioceltix Quarterly report: Q2 2025 - Filings
- 9 months ago - Certain BlackRock Sector Equity Closed-End Funds Announce Updates to Investment Objectives and Principal Investment Strategies - Business Wire